Everest Medicines

Developer of drugs for the treatment of cancer

placeNew York City, New York, United States calendar_todayFounded 2017 groups395 employees language everestmedicines.com

Social engagement

Social engagement: 6.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include Janchor Partners, RA Capital Management, Hillhouse, HBM Healthcare Investments; 2 have since exited.

Investor typeCountShare
Venture capital857%
Private equity321%
Other / undisclosed321%

Recent activity

26 Jun 2026
Milestone
regulatory
9 Jun 2026
Partnership
Jiangsu Vcare PharmaTech Co., Ltd.
4 Jun 2026
Partnership
Travere Therapeutics, Inc.
Coming soon